Pulsara Around the World - March 2026
February Recap From neuroscience symposiums to EMS expos, our teams traveled to five shows in February. Our events schedule is slowing down in March....
1 min read
Hannah Ostrem
:
Jun 05, 2019
A recent study examined the efficacy of low-dose ketamine administered intravenously as an alternative to IV fentanyl in the prehospital environment for severe pain.
The retrospective review matched patients who received solely ketamine or fentanyl according to baseline levels of pain, on a one-to-one ratio and compared those pain levels to post-treatment pain scores. Results indicated that, compared to the group who received fentanyl IV, ketamine IV patients showed a significantly larger reduction in pain after treatment. Additionally, significantly more patients receiving the ketamine IV achieved at least a 50% reduction in pain compared to those receiving fentanyl IV (67% vs. 19%, p < 0.001).
Researchers also noted that "vital signs demonstrated a nonsignificant decrease in blood pressure, respiratory rate, heart rate, and GCS. No clinically significant adverse events were reported for patients receiving ketamine IV."
These findings add to the research indicating that ketamine could be used as an effective prehospital analgesic in place of fentanyl. What are your thoughts on replacing fentanyl with a low dose of ketamine for pain control in EMS?
February Recap From neuroscience symposiums to EMS expos, our teams traveled to five shows in February. Our events schedule is slowing down in March....
January Recap The start of 2026 was on the slow side for our events schedule, with our team heading to the Florida Fire & EMS Conference, the...
Recent research shows how Pulsara was successfully leveraged to connect more than 6,000 COVID-19 patients to monoclonal antibody infusion centers via...